Future Market Insights Predicts Robust Growth for Fertility Test Market, CAGR of 7.9% from 2024 to 2034 [Yahoo! Finance]
GeneDx Holdings Corp. - Class A (WGS)
Company Research
Source: Yahoo! Finance
However, a lack of awareness poses a potential challenge. Read the full report today and unlock the potential of this dynamic market. NEWARK, Del. Feb. 6, 2024 /PRNewswire/ -- The fertility test market is expected to be valued at US$ 548.4 million in 2024 and is anticipated to experience robust growth from 2024 to 2034, exhibiting a CAGR of 7.9% . Future Market Insight's projections indicate that by 2034, the market is poised to surpass the US$ 1.2 billion mark. Request Exclusive Sample Report: Fertility Test Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18940 In addition to rising infertility rates, there has been growing awareness about fertility testing options. More people are becoming educated on the importance of fertility testing and the benefits it can provide. This has led to an increased demand for fertility testing services as more individuals seek to take control of their reproductive health and make informed decisions about
Show less
Read more
Impact Snapshot
Event Time:
WGS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WGS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WGS alerts
High impacting GeneDx Holdings Corp. - Class A news events
Weekly update
A roundup of the hottest topics
WGS
News
- GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease DatasetGlobeNewswire
- GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at BTIG Research from $11.00 to $15.00. They now have a "buy" rating on the stock.MarketBeat
- GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $6.00 to $11.00. They now have a "neutral" rating on the stock.MarketBeat
- GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024GlobeNewswire
- Dr. Marra Francis Joins Genece Health as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
WGS
Earnings
- 10/30/23 - Miss
WGS
Sec Filings
- 3/19/24 - Form 4
- 3/19/24 - Form 4
- 3/19/24 - Form 4
- WGS's page on the SEC website